106 related articles for article (PubMed ID: 15136984)
1. Therapeutic response to pentoxifylline and its active metabolites in dogs with familial canine dermatomyositis.
Rees CA; Boothe DM
Vet Ther; 2003; 4(3):234-41. PubMed ID: 15136984
[TBL] [Abstract][Full Text] [Related]
2. Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in normal dogs.
Rees CA; Boothe DM; Boeckh A; Wilkie S; Esparza T; Green R
Vet Ther; 2003; 4(2):188-96. PubMed ID: 14506595
[TBL] [Abstract][Full Text] [Related]
3. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
Sadeghian G; Nilforoushzadeh MA
Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518
[TBL] [Abstract][Full Text] [Related]
4. Interconversion and tissue distribution of pentoxifylline and lisofylline in mice.
Wyska E; Pekala E; Szymura-Oleksiak J
Chirality; 2006 Aug; 18(8):644-51. PubMed ID: 16721727
[TBL] [Abstract][Full Text] [Related]
5. Familial canine dermatomyositis: clinicopathologic, immunologic, and serologic studies.
Haupt KH; Prieur DJ; Hargis AM; Cowell RL; McDonald TL; Werner LL; Evermann JF
Am J Vet Res; 1985 Sep; 46(9):1870-5. PubMed ID: 3901838
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
Münster M; Hörauf A; Bilzer T
Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism.
Vaughan MA; Feldman EC; Hoar BR; Nelson RW
J Am Vet Med Assoc; 2008 May; 232(9):1321-8. PubMed ID: 18447776
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses.
Liska DA; Akucewich LH; Marsella R; Maxwell LK; Barbara JE; Cole CA
Am J Vet Res; 2006 Sep; 67(9):1621-7. PubMed ID: 16948611
[TBL] [Abstract][Full Text] [Related]
9. Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane.
Frank LA; Hnilica KA; Oliver JW
Vet Dermatol; 2004 Oct; 15(5):278-84. PubMed ID: 15500479
[TBL] [Abstract][Full Text] [Related]
10. Linkage of dermatomyositis in the Shetland Sheepdog to chromosome 35.
Clark LA; Credille KM; Murphy KE; Rees CA
Vet Dermatol; 2005 Dec; 16(6):392-4. PubMed ID: 16359306
[TBL] [Abstract][Full Text] [Related]
11. Familial canine dermatomyositis: clinical, electrodiagnostic, and genetic studies.
Haupt KH; Prieur DJ; Moore MP; Hargis AM; Hegreberg GA; Gavin PR; Johnson RS
Am J Vet Res; 1985 Sep; 46(9):1861-9. PubMed ID: 4051292
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of adverse effects of long-term orally administered carprofen in dogs.
Raekallio MR; Hielm-Björkman AK; Kejonen J; Salonen HM; Sankari SM
J Am Vet Med Assoc; 2006 Mar; 228(6):876-80. PubMed ID: 16536696
[TBL] [Abstract][Full Text] [Related]
13. Familial canine dermatomyositis. Initial characterization of the cutaneous and muscular lesions.
Hargis AM; Haupt KH; Hegreberg GA; Prieur DJ; Moore MP
Am J Pathol; 1984 Aug; 116(2):234-44. PubMed ID: 6465285
[TBL] [Abstract][Full Text] [Related]
14. Dermatomyositis in a family of Working Kelpies.
Röthig A; Rüfenacht S; Welle MM; Thom N
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2015; 43(5):331-6. PubMed ID: 26105578
[TBL] [Abstract][Full Text] [Related]
15. Pradofloxacin in the treatment of canine deep pyoderma: a multicentred, blinded, randomized parallel trial.
Mueller RS; Stephan B
Vet Dermatol; 2007 Jun; 18(3):144-51. PubMed ID: 17470228
[TBL] [Abstract][Full Text] [Related]
16. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
London CA; Malpas PB; Wood-Follis SL; Boucher JF; Rusk AW; Rosenberg MP; Henry CJ; Mitchener KL; Klein MK; Hintermeister JG; Bergman PJ; Couto GC; Mauldin GN; Michels GM
Clin Cancer Res; 2009 Jun; 15(11):3856-65. PubMed ID: 19470739
[TBL] [Abstract][Full Text] [Related]
17. Primary hypoparathyroidism in dogs: a retrospective study of 17 cases.
Russell NJ; Bond KA; Robertson ID; Parry BW; Irwin PJ
Aust Vet J; 2006 Aug; 84(8):285-90. PubMed ID: 16911229
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of once-daily cephalexin in canine superficial pyoderma: an open controlled study.
Toma S; Colombo S; Cornegliani L; Persico P; Galzerano M; Gianino MM; Noli C
J Small Anim Pract; 2008 Aug; 49(8):384-91. PubMed ID: 18631220
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans.
Nicklasson M; Björkman S; Roth B; Jönsson M; Höglund P
Chirality; 2002 Aug; 14(8):643-52. PubMed ID: 12125034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
